Vanguard Group Inc Aquestive Therapeutics, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,662,132 shares of AQST stock, worth $30.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,662,132

Previous 4,328,505 30.81%

Holding current value

$30.5 Million

Previous $14.3 Million 120.92%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$3.4 - $5.99 $4.53 Million - $7.99 Million	1,333,627 Added 30.81%	5,662,132 $31.7 Million
Q2 2025 Aug 11, 2025	BUY	$2.22 - $3.58 $565,982 - $912,710	254,947 Added 6.26%	4,328,505 $14.3 Million
Q1 2025 May 09, 2025	SELL	$2.54 - $3.75 $693,917 - $1.02 Million	-273,196 Reduced 6.29%	4,073,558 $11.8 Million
Q4 2024 Feb 11, 2025	BUY	$3.46 - $5.64 $287,034 - $467,883	82,958 Added 1.95%	4,346,754 $15.4 Million
Q3 2024 Nov 13, 2024	BUY	$2.4 - $5.09 $86,697 - $183,871	36,124 Added 0.85%	4,263,796 $21.2 Million
Q2 2024 Aug 13, 2024	BUY	$2.31 - $4.5 $2.28 Million - $4.43 Million	985,101 Added 30.38%	4,227,672 $11 Million
Q1 2024 May 10, 2024	BUY	$2.01 - $6.09 $2.72 Million - $8.24 Million	1,353,518 Added 71.65%	3,242,571 $13.8 Million
Q4 2023 Feb 14, 2024	BUY	$1.29 - $2.47 $245,617 - $470,290	190,401 Added 11.21%	1,889,053 $3.82 Million
Q3 2023 Nov 14, 2023	BUY	$1.5 - $2.24 $208,476 - $311,324	138,984 Added 8.91%	1,698,652 $2.6 Million
Q2 2023 Aug 14, 2023	BUY	$1.06 - $2.49 $264,026 - $620,214	249,082 Added 19.01%	1,559,668 $2.57 Million
Q1 2023 May 15, 2023	BUY	$0.72 - $1.15 $47,414 - $75,732	65,854 Added 5.29%	1,310,586 $1.49 Million
Q4 2022 Feb 10, 2023	BUY	$0.77 - $1.18 $48,657 - $74,566	63,192 Added 5.35%	1,244,732 $1.12 Million
Q3 2022 Nov 14, 2022	SELL	$0.63 - $1.73 $63,608 - $174,671	-100,966 Reduced 7.87%	1,181,540 $1.38 Million
Q1 2022 May 13, 2022	BUY	$2.28 - $4.26 $91,922 - $171,750	40,317 Added 3.25%	1,282,506 $3.35 Million
Q4 2021 Feb 14, 2022	BUY	$3.69 - $6.37 $693,295 - $1.2 Million	187,885 Added 17.82%	1,242,189 $4.83 Million
Q3 2021 Nov 12, 2021	BUY	$3.25 - $4.66 $26,734 - $38,333	8,226 Added 0.79%	1,054,304 $4.6 Million
Q2 2021 Aug 13, 2021	BUY	$3.29 - $5.21 $3.44 Million - $5.45 Million	1,046,078 New	1,046,078 $4.15 Million

Others Institutions Holding AQST

# of Institutions

162

Shares Held

65.9M

Call Options Held

794K

Put Options Held

457K

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $288M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Aquestive Therapeutics, Inc. Transaction History